Safety and Efficacy of GENOSS® DCB With a Shellac Plus Vitamin E Excipient in Patients With De Novo Lesion

Korábbi kezelés

• If it falls under any of the following items after prior dilation of the target lesion;
  • Stent procedures are required due to vascular detachment that limits blood flow
  • If the residual stenosis is >30%
  • If the TIMI flow is <3

Életkor

• Subjects who plan to become pregnant during the period of this study as women of the gestational age

Egyéb

• Subjects whose remaining life expectancy is expected to be less than one year
• Subjects who visited the hospital due to psychogenic shock at the time of visiting the hospital and are predicted to have a low chance of survival based on medical judgment
• Subjects participating in a randomized study of medical devices
• If the researcher determines that it is not appropriate for this clinical study or may increase the risk associated with participation in the study

• Adults over the age of 19
• Patients with new lesions with coronary small vascular disease (vascular diameter <3.0 mm) underwent a GENOSS® DCB procedure through percutaneous coronary intervention
• Subjects who agreed to the clinical research plan and the clinical follow-up plan, voluntarily decided to participate in this clinical study, and agreed in writing to the consent of the study subjects